Cargando…

What do we do about atrial high rate episodes?

Atrial high rate episodes (AHREs) are defined as asymptomatic atrial tachyarrhythmias detected by cardiac implantable electronic devices with atrial sensing, providing automated continuous monitoring and tracings storage, occurring in subjects with no previous clinical atrial fibrillation (AF) and w...

Descripción completa

Detalles Bibliográficos
Autores principales:	Boriani, Giuseppe, Vitolo, Marco, Imberti, Jacopo Francesco, Potpara, Tatjana S, Lip, Gregory Y H
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2020
Materias:	Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7753882/ https://www.ncbi.nlm.nih.gov/pubmed/33380943 http://dx.doi.org/10.1093/eurheartj/suaa179

Ejemplares similares

Atrial fibrillation in pneumonia: what clinical implications at long-term?
por: Vitolo, Marco, et al.
Publicado: (2022)

Yield of diagnosis and risk of stroke with screening strategies for atrial fibrillation: a comprehensive review of current evidence
por: Corica, Bernadette, et al.
Publicado: (2023)

Atrial High-Rate Episodes Detected by Cardiac Implantable Electronic Devices: Dynamic Changes in Episodes and Predictors of Incident Atrial Fibrillation
por: Imberti, Jacopo Francesco, et al.
Publicado: (2022)

New Perspectives on Risk Stratification and Treatment in Patients with Atrial Fibrillation: An Analysis of Recent Contributions on the Journal of Cardiovascular Disease and Development
por: Boriani, Giuseppe, et al.
Publicado: (2023)

Are atrial high rate episodes (AHREs) a precursor to atrial fibrillation?
por: Khan, Ahsan A., et al.
Publicado: (2019)

Factors Associated with Progression of Atrial Fibrillation and Impact on All-Cause Mortality in a Cohort of European Patients
por: Vitolo, Marco, et al.
Publicado: (2023)

Q&A: What do we know about influenza and what can we do about it?
por: Doherty, Peter C, et al.
Publicado: (2009)

Clinical complexity and impact of the ABC (Atrial fibrillation Better Care) pathway in patients with atrial fibrillation: a report from the ESC-EHRA EURObservational Research Programme in AF General Long-Term Registry
por: Romiti, Giulio Francesco, et al.
Publicado: (2022)

Real-world applicability and impact of early rhythm control for European patients with atrial fibrillation: a report from the ESC-EHRA EORP-AF Long-Term General Registry
por: Proietti, Marco, et al.
Publicado: (2021)

Impact of clinical phenotypes on management and outcomes in European atrial fibrillation patients: a report from the ESC-EHRA EURObservational Research Programme in AF (EORP-AF) General Long-Term Registry
por: Proietti, Marco, et al.
Publicado: (2021)

Clinical Phenotype Classification of Atrial Fibrillation Patients Using Cluster Analysis and Associations with Trial-Adjudicated Outcomes
por: Vitolo, Marco, et al.
Publicado: (2021)

Multiple Myeloma: What Do We Do About Immunodeficiency?
por: Li, Linrong, et al.
Publicado: (2019)

Atrial high rate episodes in patients with cardiac implantable electronic devices: implications for clinical outcomes
por: Miyazawa, Kazuo, et al.
Publicado: (2019)

Ventricular and Atrial Remodeling after Transcatheter Edge-to-Edge Repair: A Pilot Study
por: Albini, Alessandro, et al.
Publicado: (2022)

Impact of renal impairment on atrial fibrillation: ESC‐EHRA EORP‐AF Long‐Term General Registry
por: Ding, Wern Yew, et al.
Publicado: (2022)

What do we know about neutrinos?
por: Vannucci, François
Publicado: (1994)

What can we do about osteoarthritis?
por: Lohmander, L Stefan
Publicado: (2000)

What Shall We Do about Porcelain?
Publicado: (1904)

What Shall We Do about Porcelain
por: Honey, Edgar A.
Publicado: (1903)

What should we do about monkeypox?
por: Chen, Si, et al.
Publicado: (2022)

What do we know about pseudodementia?
por: Mouta, Salomé, et al.
Publicado: (2023)

Arterial Stiffness—What Do We Know about It and What Do We Expect from This Biomarker?
por: Reiner, Željko
Publicado: (2022)

A Review of the Opioid Epidemic: What Do We Do About It?
por: Shipton, Edward A., et al.
Publicado: (2018)

Optimizing indices of atrial fibrillation susceptibility and burden to evaluate atrial fibrillation severity, risk and outcomes
por: Boriani, Giuseppe, et al.
Publicado: (2021)

Publisher’s note to: Optimizing indices of atrial fibrillation susceptibility and burden to evaluate atrial fibrillation severity, risk and outcomes
por: Boriani, Giuseppe, et al.
Publicado: (2022)

What do we talk about when we talk about rhythm?
por: Obleser, Jonas, et al.
Publicado: (2017)

What Do We Talk About When We Talk About Frailty?
por: Falchetti, Alberto, et al.
Publicado: (2021)

Cosmic debris: what it is and what we can do about it
por: Powell, Jonathan
Publicado: (2017)

Neuropathic pain; what we know and what we should do about it
por: Smith, Peter A.
Publicado: (2023)

Contemporary management of atrial fibrillation and the predicted vs. absolute risk of ischaemic stroke despite treatment: a report from ESC-EHRA EORP-AF Long-Term General Registry
por: Ding, Wern Yew, et al.
Publicado: (2022)

What We Do and Do Not Know about Teaching Medical Image Interpretation
por: Kok, Ellen M., et al.
Publicado: (2017)

What we do and do not know about managing respiratory disease in pregnancy
por: Kent, Brian D.
Publicado: (2022)

What do we know about the Higgs boson ?
por: Gambino, Paulo
Publicado: (2002)

Incoming asteroid!: what could we do about it?
por: Lunan, Duncan
Publicado: (2014)

What do We Know about Neonatal Cognition?
por: Streri, Arlette, et al.
Publicado: (2013)

What Do We Know about Opioids and the Kidney?
por: Mallappallil, Mary, et al.
Publicado: (2017)

What do we know about Tietze’s syndrome?
por: Rokicki, Wojciech, et al.
Publicado: (2018)

What Should We Do about Mild Hypertension?
por: Barritt, D. W.
Publicado: (1982)

Racism in science: what can we do about it?
Publicado: (2020)

What Do We Know about Nociplastic Pain?
por: Bułdyś, Kacper, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_tv090aroh5njio1hi85snfi0a4